View ICR - OIRA Conclusion



0910-0681 201811-0910-003
Historical Active 201704-0910-004
HHS/FDA CBER
Use of Serological Tests to Reduce the Risk of Transfusion-Transmitted Infection in Whole Blood and Blood Components; Agency Guidance
No material or nonsubstantive change to a currently approved collection   No
Regular
Approved without change 12/07/2018
12/06/2018
  Inventory as of this Action Requested Previously Approved
06/30/2020 06/30/2020 06/30/2020
1 0 1
1 0 1
0 0 0